10.1016/S2213-2600(25)00019-0 Summary Keywords dipeptidyl peptidase 1 inhibitors, neutrophil serine proteases, non-cystic fibrosis bronchiectasis, chronic obstructive pulmonary disease, brensocatib, BI 1291583, HSK31858, clinical trials Citation Zhang D, Zhang W, Hu P and Zhang W (2025) Dipeptidyl peptidase 1 inhibitors for inflammatory respiratory diseases: mechanisms, clinical trials, and therapeutic prospects
doi: 10.1007/s10456-022-09835-8
The mechanism that causes false positives for ibuprofen (cyclooxygenase inhibitor with ketone-containing ring structure) or pseudoephedrine (phenethylamine derivative) simply has no analog in semaglutide biochemistry
However, the albumin level was lower, the bilirubin level was higher, and ChildPugh grade was more aggravated in the l-carnitine than that in the control group
[Abstract] Cochrane Library Olmastroni E , et al